中文 | English
Return
Total: 810 , 1/81
Show Home Prev Next End page: GO
MeSH:(Liver Diseases, Alcoholic)

1.Pseudolaric Acid B Alleviates Non-alcoholic Fatty Liver Disease by Targeting PPARα to Regulate Lipid Metabolism and Promote Mitochondrial Biogenesis.

Shu-Yan LIU ; Xiao-Wei ZHANG ; Gai GAO ; Chang-Xin LIU ; Hui CHEN ; Zhong-Xue FU ; Jiang-Yan XU ; Zhen-Zhen WANG ; Zhen-Qiang ZHANG ; Zhi-Shen XIE

Chinese journal of integrative medicine 2025;31(10):877-888

2.Research progress in the role of gut microbiota in ethanol metabolism.

Yuchun YANG ; Xiaojie ZHANG ; Ti CHEN

Journal of Central South University(Medical Sciences) 2025;50(3):501-510

3.Research progress in the role of caspase-3 in regulating pyroptosis and apoptosis in non-alcoholic fatty liver disease.

Saiying CAO ; Yi LONG ; Lina YANG

Journal of Central South University(Medical Sciences) 2025;50(6):1060-1066

4.Mediating role of insulin resistance in the relationship between hypertension and NAFLD and construction of its risk prediction model.

Yaxuan HE ; Honghui HE ; Yu CAO ; Fang WANG

Journal of Central South University(Medical Sciences) 2025;50(7):1188-1201

5.Association of metabolic dysfunction-associated fatty liver disease with coronary artery calcification among Filipino patients in a tertiary hospital in Cebu City

Mary Grace S. Nepomuceno ; Michael Albert M. Diy ; Aileen Mae L. Catapang

Philippine Journal of Internal Medicine 2025;63(1):39-44

6.The diagnostic value of Fibrosis-4 Score (FIB-4) in detecting non-alcoholic fatty liver disease among adults with type 2 diabetes mellitus

Jennifer Lourdes de Leon Ng ; Luz Margaret Alanes Escueta ; Gabriel V. Jasul Jr. ; Oliver Allan C. Dampil ; Juliet L. Gopez-Cervates

Philippine Journal of Internal Medicine 2025;63(2):91-98

7.The association of Fibrosis-4 (FIB 4) index with chronic kidney disease among type 2 diabetes mellitus patients with concomitant non-alcoholic fatty liver disease: A single center cross-sectional study

Antonio O. Pescador Jr. ; Gabriel V. Jasul Jr. ; Oliver Allan C. Dampil ; Juliet L. Gopez-Cervantes ; Luz Margaret A. Escueta

Philippine Journal of Internal Medicine 2025;63(2):138-145

8.Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: Findings from the Global Burden of Disease Study 2021.

Xinyu ZHAO ; Dong XU ; Wei JI ; Zhengzhao LU ; Cheng HUANG ; Jingjie ZHAO ; Tingting XIAO ; Dongxu WANG ; Yuanyuan KONG ; Jidong JIA ; Hong YOU

Chinese Medical Journal 2025;138(14):1741-1751

9.Advances in the function and mechanisms of stearoyl-CoA desaturase 1 in metabolic diseases.

Qin SUN ; Xiao-Rui XING ; Cheng LIU ; Dan-Dan JIA ; Ru WANG

Acta Physiologica Sinica 2025;77(3):545-562

10.Research progress in mechanisms of traditional Chinese medicine polysaccharides in prevention and treatment of alcoholic liver disease.

Yu-Fan CHEN ; He JIANG ; Qing MA ; Qi-Han LUO ; Shuo HUANG ; Jiang QIU ; Fu-Zhe CHEN ; Zi-Yi SHAN ; Ping QIU

China Journal of Chinese Materia Medica 2025;50(2):356-362

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 810 , 1/81 Show Home Prev Next End page: GO